Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimiyasu Shiraki

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Advances in Experimental Medicine and Biology|June 14, 2018
Antiviral Drugs Against AlphaherpesvirusKimiyasu Shiraki
Pharmacology & Therapeutics|February 26, 2020
Favipiravir, an anti-influenza drug against life-threatening RNA virus infectionsKimiyasu Shiraki, Tohru Daikoku
Journal of Medical Virology|October 27, 2009
Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefectureNozomu Toyama, Kimiyasu Shiraki,
Journal of Dermatological Science|July 26, 2018
Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effectNozomu Toyama, Kimiyasu Shiraki,
The Journal of General Virology|October 17, 2001
Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovirTomoko Kamiyama, Masahiko Kurokawa, Kimiyasu Shiraki
Expert Review of Anti-Infective Therapy|April 15, 2021
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatmentKimiyasu Shiraki, Masaya Takemoto, Tohru Daikoku
Antiviral Research|June 27, 2006
Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virusMikiko Suzuki, Tomoko Okuda, Kimiyasu Shiraki
The Journal of Dermatology|April 15, 2003
Role of neutralizing antibody in the pathogenesis of zoster and the correlation of severity with anti-gE: gI antibody responseKoma Matsuo, Mariko Honda, Kimiyasu Shiraki
Viruses|January 28, 2026
Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral VaccinesKimiyasu Shiraki, Takashi Kawana, Richard J Whitley
Viruses|August 28, 2021
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes ZosterKimiyasu Shiraki, Shinichiro Yasumoto, Nozomu Toyama, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Advances in Experimental Medicine and Biology|June 14, 2018
Antiviral Drugs Against AlphaherpesvirusKimiyasu Shiraki
Pharmacology & Therapeutics|February 26, 2020
Favipiravir, an anti-influenza drug against life-threatening RNA virus infectionsKimiyasu Shiraki, Tohru Daikoku
Journal of Medical Virology|October 27, 2009
Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefectureNozomu Toyama, Kimiyasu Shiraki,
Journal of Dermatological Science|July 26, 2018
Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effectNozomu Toyama, Kimiyasu Shiraki,
The Journal of General Virology|October 17, 2001
Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovirTomoko Kamiyama, Masahiko Kurokawa, Kimiyasu Shiraki
Expert Review of Anti-Infective Therapy|April 15, 2021
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatmentKimiyasu Shiraki, Masaya Takemoto, Tohru Daikoku
Antiviral Research|June 27, 2006
Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virusMikiko Suzuki, Tomoko Okuda, Kimiyasu Shiraki
The Journal of Dermatology|April 15, 2003
Role of neutralizing antibody in the pathogenesis of zoster and the correlation of severity with anti-gE: gI antibody responseKoma Matsuo, Mariko Honda, Kimiyasu Shiraki
Viruses|January 28, 2026
Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral VaccinesKimiyasu Shiraki, Takashi Kawana, Richard J Whitley
Viruses|August 28, 2021
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes ZosterKimiyasu Shiraki, Shinichiro Yasumoto, Nozomu Toyama, et al.
Pageof 11